TABLE OF CONTENTS

Volume 3, Issue 1 (2003)

Top

Editorial

The Pharmacogenomics Journal: the official journal of the International Society of Pharmacogenomics (ISP) FREE

Julio Licinio

Pharmacogenomics J 3: 1; doi:10.1038/sj.tpj.6500165

Top

In This Issue

In This Issue FREE

Pharmacogenomics J 3: 2; doi:10.1038/sj.tpj.6500161

Top

News and Commentaries

Cytochrome P450 3A pharmacogenetics: the road that needs traveled FREE

D A Flockhart and J M Rae

Pharmacogenomics J 3: 3-5; doi:10.1038/sj.tpj.6500144

Polymorphic CYP2A6 and its clinical and toxicological significance FREE

A Rautio

Pharmacogenomics J 3: 6-7; doi:10.1038/sj.tpj.6500154

Top

Perspective

The challenges of recording phenotype in a generalizable and computable form FREE

P M Nadkarni

Pharmacogenomics J 3: 8-10; doi:10.1038/sj.tpj.6500153

Top

Clinical Implication

Attention-deficit/hyperactivity disorder: current aspects on pharmacogenetics FREE

L A Rohde, T Roman and M H Hutz

Pharmacogenomics J 3: 11-13; doi:10.1038/sj.tpj.6500158

Top

EELS (Ethical, Economic, Legal & Social) Article

Pharmacogenetics: the ethical issues FREE

P Lipton

Pharmacogenomics J 3: 14-16; doi:10.1038/sj.tpj.6500159

Top

Original Articles

Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients FREE

M Holthe, T N Rakvåg, P Klepstad, J R Idle, S Kaasa, H E Krokan and F Skorpen

Pharmacogenomics J 3: 17-26; doi:10.1038/sj.tpj.6500139

Transcriptional profiling in the human prefrontal cortex: evidence for two activational states associated with cocaine abuse FREE

E Lehrmann, J Oyler, M P Vawter, T M Hyde, B Kolachana, J E Kleinman, M A Huestis, K G Becker and W J Freed

Pharmacogenomics J 3: 27-40; doi:10.1038/sj.tpj.6500146

Analysis of gene expression in carbon tetrachloride-treated rat livers using a novel bioarray technology FREE

M B Young, M R DiSilvestro, T J Sendera, J Freund, A Kriete and S R Magnuson

Pharmacogenomics J 3: 41-52; doi:10.1038/sj.tpj.6500147

Role of polymorphic human CYP2B6 in cyclophosphamide bioactivation FREE

H-J Xie, Ü Yasar, S Lundgren, L Griskevicius, Y Terelius, M Hassan and A Rane

Pharmacogenomics J 3: 53-61; doi:10.1038/sj.tpj.6500157

Extra navigation

.

naturejobs

natureproducts


ADVERTISEMENT